Table of Contents
To view the fulltext, log-in or choose pay-per-view options:
Get Access

Efficacy of Rifampin-Moxifloxacin-Metronidazole Combination Therapy in Hidradenitis Suppurativa

Join-Lambert O.a, b, j, k · Coignard H.a, c, k · Jais J.-P.a, d · Guet-Revillet H.a, b, j, k · Poirée S.a, e · Fraitag S.a, f · Jullien V.a, g · Ribadeau-Dumas F.h, k · Thèze J.h, k · Le Guern A.-S.h, k · Behillil S.h, k · Leflèche A.i · Berche P.a, b, k · Consigny P.H.h, k · Lortholary O.a, c, k · Nassif X.a, b, j, k · Nassif A.h, k
aUniversité Paris Descartes, Faculté de Médecine Paris Descartes, bLaboratoire de Microbiologie, cService des Maladies Infectieuses et Tropicales, dService d’Informatique Médicale et de Biostatistiques, eService de Radiologie Adulte, fService d’Anatomie et de Cytologie Pathologiques, Hôpital Necker-Enfants malades, Assistance-Publique-Hôpitaux de Paris, gService de Pharmacologie Saint-Vincent-de-Paul, Assistance-Publique-Hôpitaux de Paris, hCentre Médical, iCellule d’Intervention Biologique d’Urgence Institut Pasteur (CIBU), jINSERM U1002 and kCentre d’Infectiologie Necker-Pasteur, Paris, France Dermatology 2011;222:49–58 (DOI:10.1159/000321716)

Abstract

Background: Antibiotics have been shown to improve hidradenitis suppurativa (HS) patients but complete remission is rare using these treatments. Objective: To assess the efficacy and safety of a combination of oral rifampin, moxifloxacin and metronidazole in long-lasting refractory HS. Methods: We retrospectively studied 28 consecutive HS patients including 6, 10 and 12 Hurley stage 1, 2 and 3 patients, respectively. Complete remission, defined as a clearance of all inflammatory lesions including hypertrophic scars, was the main outcome criterion of the study. Results: Complete remission was obtained in 16 patients, including 6/6, 8/10 and 2/12 patients with Hurley stage 1, 2 and 3, respectively (p = 0.0004). The median duration of treatment to obtain complete remission was 2.4 (range 0.9–6.5) and 3.8 months (range 1.6–7.4) in stage 1 and 2 patients, respectively, and 6.2 and 12 months in the 2 stage 3 patients. Main adverse events of the treatments were gastrointestinal disorders (64% of patients) and vaginal candidiasis (35% of females). Reversible tendinopathy and hepatitis occurred in 4 and 1 patient, respectively. Conclusions: Complete remission of refractory HS can be obtained using broad-spectrum antibiotics and Hurley staging is a prognostic factor of response to the treatment.

 

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50